SEC Form N-PORT · 2026-03-31
WDNA ETF Holdings
WisdomTree BioRevolution Fund reported 86 holdings. Weights reproduce the source and may not sum to exactly 100 because of cash, derivatives, rounding, liabilities, or other positions.
- Report date
- 2026-03-31
- SEC accession
- 0000940400-26-022934
- Series ID
- S000071961
- Source
- SEC Form N-PORT
All reported holdings
| Ticker | Issuer | Weight | Value (USD) | Balance |
|---|---|---|---|---|
| MRNA | Moderna Inc | 4.541784% | 102,819.2 | 2,024 NS |
| JNJ | Johnson & Johnson | 3.15288% | 71,376.48 | 292 NS |
| UTHR | United Therapeutics Corporation | 2.802697% | 63,448.86 | 107 NS |
| PFE | Pfizer Inc. | 2.738725% | 62,000.64 | 2,208 NS |
| LLY | Eli Lilly & Co. | 2.640857% | 59,785.05 | 65 NS |
| STOK | Stoke Therapeutics Inc | 2.529895% | 57,273.04 | 1,759 NS |
| NTRA | NATERA INC | 2.526542% | 57,197.14 | 286 NS |
| AMGN | Amgen Inc. | 2.346858% | 53,129.35 | 151 NS |
| TWST | Twist Bioscience Corporation | 2.315284% | 52,414.56 | 1,103 NS |
| AZN | AstraZeneca PLC | 2.282467% | 51,671.64 | 262 NS |
| GPCR | Structure Therapeutics Inc | 2.201506% | 49,838.8 | 1,034 NS |
| FOLD | Amicus Therapeutics Inc. | 2.194054% | 49,670.1 | 3,435 NS |
| BNTX | BioNTech SE | 2.092587% | 47,373.04 | 533 NS |
| IONS | Ionis Pharmaceuticals, Inc. | 2.059804% | 46,630.89 | 621 NS |
| GILD | Gilead Sciences Inc. | 1.957712% | 44,319.66 | 318 NS |
| CRSP | CRISPR Therapeutics AG | 1.872247% | 42,384.87 | 891 NS |
| IMNM | Immunome Inc | 1.862551% | 42,165.36 | 1,928 NS |
| NSISB | Novonesis (Novozymes) B | 1.852323% | 41,933.81 | 711 NS |
| BEAM | BEAM THERAPEUTICS INC | 1.816842% | 41,130.58 | 1,726 NS |
| TXG | 10X Genomics Inc | 1.781787% | 40,337 | 1,900 NS |
| DAR | Darling Ingredients, Inc | 1.699348% | 38,470.7 | 622 NS |
| NOVN | Novartis AG | 1.647683% | 37,301.08 | 248 NS |
| ROIV | Roivant Sciences Ltd | 1.599218% | 36,203.9 | 1,307 NS |
| KRYS | Krystal Biotech Inc | 1.574669% | 35,648.16 | 138 NS |
| AGIO | Agios Pharmaceuticals Inc | 1.566086% | 35,453.84 | 1,048 NS |
| BG | Bunge Global SA | 1.539536% | 34,852.8 | 274 NS |
| NOVOB | Novo Nordisk A/S | 1.48618% | 33,644.88 | 945 NS |
| NTLA | Intellia Therapeutics Inc | 1.484817% | 33,614.04 | 2,622 NS |
| CTVA | Corteva Inc | 1.449492% | 32,814.32 | 392 NS |
| ARWR | Arrowhead Pharmaceuticals Inc | 1.431892% | 32,415.9 | 517 NS |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.361011% | 30,811.26 | 69 NS |
| RGNX | Regenxbio Inc. | 1.322232% | 29,933.36 | 3,572 NS |
| ACLX | Arcellx Inc | 1.278116% | 28,934.64 | 252 NS |
| ALLO | Allogene Therapeutics Inc | 1.247457% | 28,240.56 | 11,574 NS |
| BMY | Bristol-Myers Squibb Company | 1.197542% | 27,110.55 | 447 NS |
| 4502 | Takeda Pharmaceutical Co Ltd. | 1.166908% | 26,417.05 | 742 NS |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.126272% | 25,497.12 | 33 NS |
| GMAB | Genmab As | 1.103374% | 24,978.73 | 931 NS |
| VBK | Verbio SE | 1.046627% | 23,694.07 | 449 NS |
| BMRN | Biomarin Pharmaceutical Inc. | 1.023076% | 23,160.9 | 410 NS |
| BAYN | Bayer AG | 1.014288% | 22,961.97 | 506 NS |
| ARGX | Argenx SE | 0.935453% | 21,177.25 | 29 NS |
| VKTX | Viking Therapeutics Inc. | 0.91417% | 20,695.44 | 636 NS |
| VCYT | Veracyte Inc | 0.906322% | 20,517.77 | 637 NS |
| EDIT | Editas Medicine Inc | 0.892707% | 20,209.54 | 8,182 NS |
| DHR | Danaher Corporation | 0.887762% | 20,097.6 | 106 NS |
| ARCT | Arcturus Therapeutics Holdings Inc | 0.850484% | 19,253.68 | 2,494 NS |
| ABSI | ABSCI CORP | 0.837379% | 18,957 | 6,319 NS |
| IOVA | Iovance Biotherapeutics Inc | 0.817555% | 18,508.23 | 5,273 NS |
| TEM | Tempus AI Inc. | 0.779018% | 17,635.8 | 390 NS |
| MRK | Merck & Co., Inc | 0.775773% | 17,562.34 | 146 NS |
| QURE | Uniqure N.V. | 0.75761% | 17,151.15 | 1,049 NS |
| RGEN | Repligen Corporation | 0.754639% | 17,083.9 | 145 NS |
| BIIB | Biogen Inc | 0.736932% | 16,683.03 | 91 NS |
| EXEL | Exelixis, Inc. | 0.714249% | 16,169.53 | 377 NS |
| ZTS | Zoetis Inc. | 0.684034% | 15,485.51 | 131 NS |
| RVMD | Revolution Medicines Inc | 0.657254% | 14,879.25 | 153 NS |
| SANA | Sana Biotechnology Inc | 0.636339% | 14,405.76 | 5,002 NS |
| HALO | Halozyme Therapeutics Inc | 0.633781% | 14,347.86 | 222 NS |
| GPRE | Green Plains Inc. | 0.616916% | 13,966.05 | 849 NS |
| DNA | Ginkgo Bioworks Holdings Inc | 0.593274% | 13,430.83 | 2,191 NS |
| ZEAL | Zealand Pharma As | 0.570632% | 12,918.25 | 284 NS |
| BBIO | Bridgebio Pharma Inc | 0.564203% | 12,772.72 | 172 NS |
| SYENS | Syensqo SA | 0.543956% | 12,314.34 | 216 NS |
| GERN | Geron Corp. | 0.526997% | 11,930.43 | 8,007 NS |
| RARE | Ultragenyx Pharmaceuticals Inc | 0.518232% | 11,732 | 560 NS |
| GNS | Genus PLC | 0.445912% | 10,094.77 | 323 NS |
| ILMN | Illumina Inc | 0.435576% | 9,860.8 | 80 NS |
| TECH | Bio-Techne Corp | 0.427064% | 9,668.1 | 185 NS |
| SRPT | Sarepta Therapeutics Inc | 0.41043% | 9,291.52 | 427 NS |
| SDGR | Schrodinger Inc. | 0.375346% | 8,497.28 | 748 NS |
| TSN | Tyson Foods, Inc. | 0.373578% | 8,457.24 | 132 NS |
| CRBU | Caribou Biosciences Inc | 0.370373% | 8,384.7 | 4,413 NS |
| ALNY | Alnylam Pharmaceuticals Inc. | 0.365384% | 8,271.75 | 25 NS |
| ONT | Oxford Nanopore Technologies Plc | 0.358656% | 8,119.44 | 5,557 NS |
| RXRX | Recursion Pharmaceuticals Inc | 0.32465% | 7,349.58 | 2,394 NS |
| RCKT | Rocket Pharmaceuticals Inc | 0.321494% | 7,278.14 | 2,033 NS |
| DSVXX | DREY INST PREF GOV MM-M | 0.317244% | 7,181.94 | 7,181.94 NS |
| NUF | Nufarm Ltd. | 0.279519% | 6,327.9 | 4,529 NS |
| TMO | Thermo Fisher Scientific Inc | 0.260545% | 5,898.36 | 12 NS |
| PACB | Pacific Biosciences Of California Inc. | 0.254863% | 5,769.72 | 4,371 NS |
| QGEN | QIAGEN NV | 0.23877% | 5,405.4 | 135 NS |
| FATE | Fate Therapeutics Inc. | 0.222206% | 5,030.4 | 4,192 NS |
| FMC | FMC Corp. | 0.203094% | 4,597.74 | 267 NS |
| BHVN | Biohaven Ltd | 0.145369% | 3,290.94 | 389 NS |
| DTRXX | DREYFUS TRSY OBLIG CASH M | 0.049201% | 1,113.83 | 1,113.83 NS |